Lilly's Alzheimer's drug bests Aduhelm in plaque clearance study
BioPharma
Source: biopharmadive.com
Page 28 - Mark Mintun News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Mintun Today - Breaking & Trending Today
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's Disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has announced that donanemab met all primary and secondary endpoints for the 6-month primary outcome analysis...
Source: prnewswire.com
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's Disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has announced that donanemab met all primary and secondary endpoints for the 6-month primary outcome analysis...
Source: prnewswire.com
Lilly to Participate in Goldman Sachs Global Healthcare Conference
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. Anne White,...
Source: prnewswire.com
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/tronc/4C374YBLHNA5DNGO2HYPFFWGXA.jpg)
Metro Orlando clinical trial hopes to speed up Alzheimer's diagnoses for minorities – Orlando Sentinel
Up to 100 spots are still open for a clinical trial that vows to have 20% Black and Latinx participants.
Source: orlandosentinel.com